Cargando…
CRISPR‐mediated knockout of VEGFR2/KDR inhibits cell growth in a squamous thyroid cancer cell line
Squamous and anaplastic thyroid cancers are the most aggressive and life‐threatening cancer types in humans, with the involvement of lymph nodes in 59% of cases and distant metastases in 26% of cases of all thyroid cancers. The median survival of squamous thyroid cancer patients is < 8 months and...
Autores principales: | Tsai, Ming‐Lin, Lee, Chia‐Hwa, Huang, Li‐Chi, Chen, Yu‐Hsin, Liu, Wei‐Ni, Lin, Chun‐Yu, Hsu, Kai‐Wen, Lee, Ai‐Wei, Lin, Ching‐Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063427/ https://www.ncbi.nlm.nih.gov/pubmed/35313079 http://dx.doi.org/10.1002/2211-5463.13399 |
Ejemplares similares
-
HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
por: Lin, Ching-Ling, et al.
Publicado: (2019) -
Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders
por: Pădureanu, Vlad, et al.
Publicado: (2017) -
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2019) -
CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer
por: Huang, Li-Chi, et al.
Publicado: (2018) -
Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody
por: Li, Xiaoli, et al.
Publicado: (2017)